Article Cited by others


Lorcaserin: A novel antiobesity drug

Brashier Dick B. S., Sharma A K, Dahiya Navdeep, Singh S K, Khadka Anjan

Year : 2014| Volume: 5| Issue : 2 | Page no: 175-178

   This article has been cited by
1 An in-silico study to investigate the role of ß-cryptoxanthin on obesity
Subhasis Datta, Debjani Dutta
Materials Today: Proceedings. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 New Horizons: Is Obesity a Disorder of Neurotransmission?
Alexandre Caron, Natalie Jane Michael
The Journal of Clinical Endocrinology & Metabolism. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 One-Pot, Water-Mediated, H2O2-HCl Catalyzed Synthesis of Benzazepines
Nidhi Singh, Jaya Pandey
Asian Journal of Chemistry. 2020; 32(5): 1165
[Pubmed]  [Google Scholar] [DOI]
4 Hypertension in Obesity: Novel Insights
Michail Natsis, Christina Antza, Ioannis Doundoulakis, Stella Stabouli, Vasilios Kotsis
Current Hypertension Reviews. 2020; 16(1): 30
[Pubmed]  [Google Scholar] [DOI]
5 A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study
Ekta Kapoor, Stephanie Faubion, Ryan T. Hurt, Karen Fischer, Darrell Schroeder, Shawn Fokken, Ivana T. Croghan
Menopause. 2020; 27(11): 1228
[Pubmed]  [Google Scholar] [DOI]
6 Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis
Hai Zeng, Meng Luo, Zunjiang Li, Junru Wen, Guoxin He, Yuelin Jin, Wenbin Fu, Peng Zhou
BMJ Open. 2019; 9(7): e029426
[Pubmed]  [Google Scholar] [DOI]
7 The Severity of Non-Alcoholic Fatty Liver in Type II Diabetes
Ovidiu Paul Calapod, Andreea Maria Marin, Laura Carina Tribus, Carmen Fierbinteanu-Braticevici
Internal Medicine. 2018; 15(6): 37
[Pubmed]  [Google Scholar] [DOI]
8 Lead-like Drugs: A Perspective
Brian Raymer,Samit K. Bhattacharya
Journal of Medicinal Chemistry. 2018;
[Pubmed]  [Google Scholar] [DOI]
9 Pharmacological Interventions for Obesity: Current and Future Targets
Miriam E. Bocarsly
Current Addiction Reports. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 Design and Rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) Trial
Erin A. Bohula,Benjamin M. Scirica,Christina Fanola,Silvio E. Inzucchi,Anthony Keech,Darren K. McGuire,Steven Smith,Tim Abrahamsen,Bruce H. Francis,Wenfeng Miao,Carlos A. Perdomo,Andrew Satlin,Stephen Wiviott,Marc S. Sabatine
American Heart Journal. 2018;
[Pubmed]  [Google Scholar] [DOI]
11 Novel Natural Oximes and Oxime Esters with a Vibralactone Backbone from the BasidiomyceteBoreostereum vibrans
He-Ping Chen,Zhen-Zhu Zhao,Zheng-Hui Li,Ze-Jun Dong,Kun Wei,Xue Bai,Ling Zhang,Chun-Nan Wen,Tao Feng,Ji-Kai Liu
ChemistryOpen. 2016; : n/a
[Pubmed]  [Google Scholar] [DOI]
12 Inhibition of glycine transporter-1 in the dorsal vagal complex improves metabolic homeostasis in diabetes and obesity
Jessica T. Y. Yue,Mona A. Abraham,Paige V. Bauer,Mary P. LaPierre,Peili Wang,Frank A. Duca,Beatrice M. Filippi,Owen Chan,Tony K. T. Lam
Nature Communications. 2016; 7: 13501
[Pubmed]  [Google Scholar] [DOI]
13 A Validated UPLC–MS-MS Assay for the Rapid Determination of Lorcaserin in Plasma and Brain Tissue Samples
Amal A. Bajrai,Essam Ezzeldin,Khalid A. Al-Rashood,Mohammad Raish,Muzaffar Iqbal
Journal of Analytical Toxicology. 2016; 40(2): 133
[Pubmed]  [Google Scholar] [DOI]
14 Anti-adipogenic effects in 3T3-L1 cells of acetone extracts and fractions from Styrax japonica fruit
Jin Kyu Kim,Hajin Nam,Yoo Yeon Kim,Harry Jung,Yoon Soo Choi,Joa Sub Oh,Su Kyoung Chun,Jun Gyo Suh
Food Science and Biotechnology. 2015; 24(4): 1513
[Pubmed]  [Google Scholar] [DOI]
15 Pharmacological treatment and therapeutic perspectives of metabolic syndrome
Soo Lim,Robert H. Eckel
Reviews in Endocrine and Metabolic Disorders. 2014;
[Pubmed]  [Google Scholar] [DOI]


Read this article